177 related articles for article (PubMed ID: 11225415)
1. [MR tomographic characterization of suspicious breast lesions with dynamic susceptibility-weighted T2* sequences].
Dannert S; Krück W; Schick F; Claussen CD; Müller-Schimpfle M
Rofo; 2001 Jan; 173(1):38-43. PubMed ID: 11225415
[TBL] [Abstract][Full Text] [Related]
2. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging.
Kvistad KA; Rydland J; Vainio J; Smethurst HB; Lundgren S; Fjøsne HE; Haraldseth O
Radiology; 2000 Aug; 216(2):545-53. PubMed ID: 10924584
[TBL] [Abstract][Full Text] [Related]
3. [Diagnosis of infraclinical lesions of the breast with dynamic MRI: results of a prospective and multicenter study].
Gilles R; Meunier M; Trouffléau P; Divano L; Tardivon A; Vanel D; Hacourt A; Neuenschwander S; Stinès J
J Radiol; 1997 Apr; 78(4):293-7. PubMed ID: 9239364
[TBL] [Abstract][Full Text] [Related]
4. [Combination of low and high resolution T1-weighted sequences for improved evaluation of morphologic criteria in dynamic contrast enhanced MRI of the breast].
Vomweg TW; Teifke A; Schreiber WG; Schmidt M; Thelen M
Rofo; 2002 Nov; 174(11):1445-9. PubMed ID: 12424673
[TBL] [Abstract][Full Text] [Related]
5. Feature extraction and classification of dynamic contrast-enhanced T2*-weighted breast image data.
Torheim G; Godtliebsen F; Axelson D; Kvistad KA; Haraldseth O; Rinck PA
IEEE Trans Med Imaging; 2001 Dec; 20(12):1293-301. PubMed ID: 11811829
[TBL] [Abstract][Full Text] [Related]
6. Fast 3D Near-infrared breast imaging using indocyanine green for detection and characterization of breast lesions.
Schneider P; Piper S; Schmitz CH; Schreiter NF; Volkwein N; Lüdemann L; Malzahn U; Poellinger A
Rofo; 2011 Oct; 183(10):956-63. PubMed ID: 21972043
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of dynamic susceptibility contrast MRI using echo-planar imaging in differential diagnosis of breast tumors].
Yoshino A
Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Jul; 58(8):441-6. PubMed ID: 9745258
[TBL] [Abstract][Full Text] [Related]
8. Breast carcinomas with strong high-signal intensity on T2-weighted MR images: pathological characteristics and differential diagnosis.
Yuen S; Uematsu T; Kasami M; Tanaka K; Kimura K; Sanuki J; Uchida Y; Furukawa H
J Magn Reson Imaging; 2007 Mar; 25(3):502-10. PubMed ID: 17326093
[TBL] [Abstract][Full Text] [Related]
9. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses.
Inan N; Arslan A; Akansel G; Anik Y; Balci NC; Demirci A
Eur J Radiol; 2008 Jan; 65(1):154-62. PubMed ID: 17466481
[TBL] [Abstract][Full Text] [Related]
10. Markedly high signal intensity lesions in the uterine cervix on T2-weighted imaging: differentiation between mucin-producing carcinomas and nabothian cysts.
Li H; Sugimura K; Okizuka H; Yoshida M; Maruyama R; Takahashi K; Miyazaki K
Radiat Med; 1999; 17(2):137-43. PubMed ID: 10399782
[TBL] [Abstract][Full Text] [Related]
11. [MR mammography at 0.5 tesla. I. Comparison of image quality and sensitivity of MR mammography at 0.5 and 1.5 T].
Kuhl CK; Kreft BP; Hauswirth A; Elevelt A; Steudel A; Reiser M; Schild HH
Rofo; 1995 May; 162(5):381-9. PubMed ID: 7772759
[TBL] [Abstract][Full Text] [Related]
12. MR imaging in probably benign lesions (BI-RADS category 3) of the breast.
Gökalp G; Topal U
Eur J Radiol; 2006 Mar; 57(3):436-44. PubMed ID: 16316732
[TBL] [Abstract][Full Text] [Related]
13. Can breast MRI computer-aided detection (CAD) improve radiologist accuracy for lesions detected at MRI screening and recommended for biopsy in a high-risk population?
Arazi-Kleinman T; Causer PA; Jong RA; Hill K; Warner E
Clin Radiol; 2009 Dec; 64(12):1166-74. PubMed ID: 19913125
[TBL] [Abstract][Full Text] [Related]
14. Breast neoplasms: T2* susceptibility-contrast, first-pass perfusion MR imaging.
Kuhl CK; Bieling H; Gieseke J; Ebel T; Mielcarek P; Far F; Folkers P; Elevelt A; Schild HH
Radiology; 1997 Jan; 202(1):87-95. PubMed ID: 8988196
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of chemical-shift MR imaging to differentiate between adrenal adenomas and non adenoma adrenal lesions.
Maurea S; Imbriaco M; D'Angelillo M; Mollica C; Camera L; Salvatore M
Radiol Med; 2006 Aug; 111(5):674-86. PubMed ID: 16791464
[TBL] [Abstract][Full Text] [Related]
16. Relationship between contrast enhancement on fluid-attenuated inversion recovery MR sequences and signal intensity on T2-weighted MR images: visual evaluation of brain tumors.
Kubota T; Yamada K; Kizu O; Hirota T; Ito H; Ishihara K; Nishimura T
J Magn Reson Imaging; 2005 Jun; 21(6):694-700. PubMed ID: 15906343
[TBL] [Abstract][Full Text] [Related]
17. Interactive detection and visualization of breast lesions from dynamic contrast enhanced MRI volumes.
Subramanian KR; Brockway JP; Carruthers WB
Comput Med Imaging Graph; 2004 Dec; 28(8):435-44. PubMed ID: 15541950
[TBL] [Abstract][Full Text] [Related]
18. MR imaging of medullary carcinoma of the breast.
Tominaga J; Hama H; Kimura N; Takahashi S
Eur J Radiol; 2009 Jun; 70(3):525-9. PubMed ID: 18353587
[TBL] [Abstract][Full Text] [Related]
19. Comparative utility of MRI perfusion with MSIDR and DWIBS for the characterization of breast tumors.
Zhang B; Zhu B; Li M; Yuan L; Yuan L; Zhang X; Yu H; Li C; Lu F; Zhou Z; Zhuang X
Acta Radiol; 2012 Jul; 53(6):607-14. PubMed ID: 22761342
[TBL] [Abstract][Full Text] [Related]
20. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
